Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Novato, California
- Most recent report
- 8-K, filed Aug 18, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1048477
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 41
News 8 of 104
Prospectuses and Registrations 8 of 15
- S-8 Registration statement for an employee plan Aug 6, 2026
- S-8 Registration statement for an employee plan Aug 5, 2025
- S-8 Registration statement for an employee plan Nov 2, 2023
- S-8 Registration statement for an employee plan Feb 17, 2022
- S-8 Registration statement for an employee plan Oct 16, 2019
- S-8 POS Post-effective amendment to an employee plan registration Aug 22, 2018
- S-8 POS Post-effective amendment to an employee plan registration Aug 22, 2018
- 424B5 Prospectus supplement for an offering Aug 9, 2017
Proxies 8 of 22
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 8, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEFA14A Extra proxy material Apr 9, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2024
- DEFA14A Extra proxy material Apr 11, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2023
Ownership 8 of 785
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
- 4 Insider reported a trade Jun 4, 2026
Other 8 of 33
Everything here comes from Biomarin Pharmaceutical Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.